Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jin Ji has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Fubo Wang

    Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, University Engineering Research Center of Digital Medicine and Healthcare, Guangxi Medical University, Nanning, China

    2 shared publications
  • Huan Xu

    Department of Urology, Shanghai Ninth People’s Hospital, Shanghai 200011, China

    2 shared publications
  • Chungen Yao

    Department of Urology, Haining Branch of the First Affiliated Hospital, Zhejiang University, Haining, Zhejiang Province, China

    1 shared publication
  • Da Xu

    Department of Urology, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), Shanghai, China

    1 shared publication
  • Depei Kong

    Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), 125 Changhai Road, Shanghai, 200433, China

    1 shared publication
  • Fubo Wang

    Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China

    1 shared publication

Latest Publications

  • Open Access

    Splenic Rupture Presenting 48 Hours after Colonoscopy: A Case Report Emphasizing the Need for Prolonged Monitoring

    by Yang Ding, Min Fang, Jin Ji, Gang Nie

    Splenic rupture constitutes a rare yet potentially life-threatening complication following colonoscopy. We report a case of a young male patient who presented with abdominal pain for 2 days, which began 6 hours after colonoscopy. Clinical examination revealed periumbilical tenderness, with laboratory findings significant for leukocytosis (WBC: 20.32 × 10 9 /L), an initial hemoglobin of 113 g/L, and a significantly elevated D-dimer (15.25 mg/L). Abdominal computed tomography confirmed splenic rupture, perisplenic hematoma, and hemoperitoneum. Following multidisciplinary consultation involving hepatobiliary surgery and interventional radiology, the patient underwent emergent splenic artery embolization. Post-procedural management included antibiotics and supportive care. Despite achieving hemodynamic stability and symptomatic improvement, persistent leukocytosis and a significant hemoglobin decrease to 79 g/L were noted on postoperative day 1, accompanied by radiographic evidence of increased hemoperitoneum. Nonetheless, the patient remained hemodynamically stable and received ongoing supportive care, and was discharged in good condition after a hospital stay of 15 days. This case highlights the importance of maintaining a high index of suspicion for splenic injury in patients with post-colonoscopy abdominal pain, even with delayed presentation, and demonstrates the use of splenic artery embolization as a therapeutic intervention, and the need for prolonged monitoring.

  • Open Access

    Elevated PABPC4 expression in human prostate cancer tissues predicts adverse clinical outcomes

    by Xianqi Shen, Zijian Li, Yuchuan Shi, Zenghui Zhou, Yan Wang, Min Qu, Jin Ji, Xu Gao

    Background: Poly(A) binding protein cytoplasmic 4 (PABPC4) has been regarded as a prognostic marker in many malignancies. In this study, we evaluated PABPC4 expression at both messenger ribonucleic acid (mRNA) and protein levels. The prognostic value of PABPC4 in patients with prostate cancer (PCa) was also investigated. Methods: The Cancer Genome Atlas (TCGA) database, Gene Expression Omnibus (GEO) database, our analysis of Chinese Prostate Cancer Genome and Epigenome Atlas (CPGEA), and 65 pairs of ribonucleic acid (RNA) sequencing data from our center were employed to detect the expression of PABPC4 in PCa tissues. Tissue microarrays (TMAs) were utilized to detect the expression of the PABPC4 protein, and survival analysis as well as risk factor analysis were conducted. Results: In the 65 pairs of sequencing data, the expression of PABPC4 in tumor tissues was significantly higher than that in paired adjacent tissues (PConclusions: Our study demonstrated that PABPC4 was overexpressed at mRNA and protein levels in PCa. We found that patients with high PABPC4 expression had a shorter biochemical recurrence (BCR)-free survival and OS, showing its value as a prognostic biomarker in patients with PCa.


  • Open Access

    Comparing pretreatment strategies to increase the yield and purity of human urinary extracellular vesicles

    by Chungen Yao, Xi Chen, Yalong Xu, Fubo Wang, Jin Ji, Huan Xu, Jingyi He, Lei Wang, Yun Li


  • Open Access

    A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study

    by Yun Li, Jin Ji, Ji Lyu, Xin Jin, Xing He, Shaojia Mo, Huan Xu, Jingyi He, Zhi Cao, Xi Chen, et al.

    Purpose: This study aimed at developing and validating a novel noninvasive urinary exosome-based post-DRE (digital rectal examination) lncRNA assay to diagnose PCa (prostate cancer) and clinically significant PCa (Gleason score ≥ 7) from the initial prostate biopsy. Methods: A total of 602 urine samples from eligible participants were collected. The expression levels of urinary exosomal PCA3 (prostate cancer antigen 3) and MALAT1 (metastasis-associated lung adenocarcinoma transcript 1) were detected by qPCR (quantitative real-time PCR). Receiver operating characteristic (ROC) analysis was applied to evaluate the diagnostic performance of PCA3, MALAT1 and the lncRNA assay. A decision curve analysis (DCA) and waterfall plots were used to assess the clinical value of the lncRNA assay. Results: Urinary exosomal PCA3 and MALAT1 were overexpressed in PCa and clinically significant PCa (p < 0.001). The lncRNA assay combining PCA3 and MALAT1 had a better diagnostic performance (AUC 0.828) than the current clinical parameters in detecting PCa. More importantly, the lncRNA assay yielded an AUC of 0.831 to detect clinically significant PCa, which is much higher than that of the current clinical parameters. The lncRNA assay was superior to PSA, f/tPSA and the base model for detecting PCa and clinically significant PCa, with a higher net benefit for almost all threshold probabilities. At the cutoff value of 95% sensitivity, the lncRNA assay could avoid 24.2% unnecessary biopsies while only missing 1.2% of the cases of clinically significant PCa. Conclusion: We developed and validated a novel noninvasive post-DRE urine-based lncRNA assay that presented good diagnostic power and clinical utility for the early diagnosis of PCa and high-grade PCa.


  • Replicate systematic review and meta-analyses on robotic surgery: a quality appraisal and overlap investigation

    by Jin Ji, Han Zhang, Da Xu, Tianyi Zhang, Depei Kong, Guang’an Xiao, Zhi Cao, Fubo Wang, Xu Gao, Ying-Hao Sun

    The number of publications of systematic reviews and meta-analyses (MAs) on robotic surgery have been increasing, including many investigating the same topic. Their quality and extent of overlap remains unclear. We assessed the quality of the MAs in this area and investigated the extent of their overlap.